Literature DB >> 18722134

Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery.

Masayuki Chida1, Shuichi Ono, Yasushi Hoshikawa, Takashi Kondo.   

Abstract

OBJECTIVE: Postoperative acute interstitial pneumonia is a subset of post-surgical acute respiratory distress syndrome (ARDS) and is responsible for one third of in-hospital deaths following lung resection in patients with primary lung cancer. We evaluated the usefulness of computed tomography (CT) for detection of interstitial pneumonia (IP) as a risk factor of postoperative ARDS.
METHODS: Preoperative chest CT of patients who underwent thoracotomy for primary lung cancer was reviewed retrospectively and IP findings in the chest CT were detected.
RESULTS: A total of 1148 patients with primary lung cancer underwent thoracotomy. Fifteen patients (1.3%) developed postoperative ARDS. Eleven of these 15 patients died of ARDS. Three of 41 patients who received induction therapy developed postoperative ARDS. Induction therapy was a risk factor of postoperative ARDS (p<0.01). Eleven out of the 15 patients who developed postoperative ARDS had IP findings (10: localized, 1: diffuse) in their chest CT. Two of three patients who had postoperative ARDS after induction therapy also had IP findings. Chest CTs of 834 patients were retrospectively analyzed; 91 patients (10.9%) had IP-findings (diffuse 1.8%, localized 9.1%). Postoperative ARDS occurred in 8.8% of IP-positive patients, and in 0.4% of IP-negative patients (p<0.001).
CONCLUSION: Detection of IP by chest CT is useful for the selection of high-risk patients who may have postoperative ARDS following thoracotomy.

Entities:  

Mesh:

Year:  2008        PMID: 18722134     DOI: 10.1016/j.ejcts.2008.07.028

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  16 in total

1.  Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression.

Authors:  Wen-Qin Zhou; Peng Wang; Qiu-Ping Shao; Jian Wang
Journal:  Mol Cell Biochem       Date:  2016-07-08       Impact factor: 3.396

2.  Postoperative pyothorax a risk factor for acute exacerbation of idiopathic interstitial pneumonia following lung cancer resection.

Authors:  Satoru Kobayashi; Yoko Karube; Morimichi Nishihira; Takashi Inoue; Osamu Araki; Sumiko Maeda; Tetsu Sado; Yuji Matsumura; Masayuki Chida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-06-08

Review 3.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 4.  Subclinical interstitial lung disease: why you should care.

Authors:  Tracy J Doyle; Gary M Hunninghake; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2012-02-23       Impact factor: 21.405

Review 5.  Telomeres and age-related disease: how telomere biology informs clinical paradigms.

Authors:  Mary Armanios
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

6.  Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis.

Authors:  Shinsaku Yamaguchi; Takayuki Ohguri; Yuichi Matsuki; Katsuya Yahara; Hodaka Oki; Hajime Imada; Hiroyuki Narisada; Yukunori Korogi
Journal:  Int J Clin Oncol       Date:  2014-03-11       Impact factor: 3.402

7.  Prediction of postoperative exacerbation of interstitial pneumonia in patients with lung cancer and interstitial lung disease.

Authors:  Akira Iyoda; Shi-Xu Jiang; Hideki Amano; Fumihiro Ogawa; Yoshio Matui; Naomi Kurouzu; Hidenori Hara; Kenji Nezu; Tetsuo Mikami; Makoto Saegusa; Yukitoshi Satoh
Journal:  Exp Ther Med       Date:  2011-08-24       Impact factor: 2.447

8.  Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions.

Authors:  Yin P Hung; Gary M Hunninghake; Ezra R Miller; Rachel Putman; Mizuki Nishino; Tetsuro Araki; Hiroto Hatabu; Lynette M Sholl; Marina Vivero
Journal:  Hum Pathol       Date:  2019-01-15       Impact factor: 3.466

9.  Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.

Authors:  Takekazu Iwata; Shigetoshi Yoshida; Kaoru Nagato; Takahiro Nakajima; Hidemi Suzuki; Tetsuzo Tagawa; Teruaki Mizobuchi; Satoshi Ota; Yukio Nakatani; Ichiro Yoshino
Journal:  Surg Today       Date:  2014-11-22       Impact factor: 2.549

10.  Inflammation-Based Prognostic Score Predicts Postoperative Survival of Patients with Interstitial Pneumonia After Undergoing Lung Cancer Resection.

Authors:  Satoru Kobayashi; Yuji Matsumura; Yoko Karube; Morimichi Nishihira; Takashi Inoue; Osamu Araki; Sumiko Maeda; Masayuki Chida
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.